Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis

被引:0
作者
Katsuichi Ohtsuki
Koichi Akashi
Yoshikazu Aoka
Francis G. Blankenberg
Susan Kopiwoda
Jonathan F. Tait
H. William Strauss
机构
[1] Division of Nuclear Medicine,
[2] Department of Radiology,undefined
[3] Stanford University Medical Center,undefined
[4] Stanford,undefined
[5] USA,undefined
[6] Departments of Pathology and Developmental Medicine,undefined
[7] Stanford University Medical Center,undefined
[8] Stanford,undefined
[9] USA,undefined
[10] Division of Cardiology,undefined
[11] Department of Medicine,undefined
[12] Stanford University Medical Center,undefined
[13] Stanford,undefined
[14] USA,undefined
[15] Department of Laboratory Medicine,undefined
[16] University of Washington,undefined
[17] Seattle,undefined
[18] USA,undefined
[19] Division of Nuclear Medicine,undefined
[20] Stanford University Medical Center,undefined
[21] Room H0101,undefined
[22] 300 Pasteur Dr.,undefined
[23] Stanford CA 94305,undefined
[24] USA,undefined
来源
European Journal of Nuclear Medicine | 1999年 / 26卷
关键词
Key words: Apoptosis; Annexin V; Technetium-99m;
D O I
暂无
中图分类号
学科分类号
摘要
Either inadequate or excessive apoptosis (programmed cell death) is associated with many diseases. A method to image apoptosis in vivo, rather than requiring histologic evaluation of tissue, could assist with therapeutic decision making in these disorders. Programmed cell death is associated with a well-choreographed series of events resulting in the cessation of normal cell function, and the ultimate disappearance of the cell. One component of apoptosis is signaling adjacent cells that this cell is committing suicide by externalizing phosphatidylserine to the outer leaflet of the cell membrane. Annexin V, a 32-kDa endogenous human protein, has a high affinity for membrane-bound phosphatidylserine. We have coupled annexin V with the bifunctional hydrazinonicotinamide reagent (HYNIC) to prepare technetium-99m HYNIC-annexin V and demonstrated localization of radioactivity in tissues undergoing apoptosis in vivo. In this report we describe the results of a series of experiments in mice and rats to characterize the biologic behavior of 99mTc-HYNIC- annexin V. Biodistribution studies were performed in groups of rats at 10–180 min after intravenous injection of 99mTc-HYNIC-annexin V. In order to estimate the degree of apoptosis required for localization of 99mTc-annexin V in vivo, mice were treated with dexamethasone at doses ranging from 1 to 20 mg/kg, 5 h prior to 99mTc-HYNIC-annexin V administration, to induce thymic apoptosis. Thymus was excised 1 h after radiolabeled HYNIC-annexin V injection; thymocytes were isolated, incubated with Hoechst 33342 followed by propidium iodide, and analyzed on a fluorescence-activated cell sorter. Each sorted cell population was counted in a scintillation counter. To test 99mTc-HYNIC-annexin V as a tracer for external radionuclide imaging of apoptotic cell death, radionuclide imaging of Fas-defective mice (lpr/lpr mice) and wild-type mice treated with the antibody to Fas (anti-Fas) was carried out 1 h post injection. Rat biodistribution studies demonstrated a blood clearance half-time of less than 10 min for 99mTc-HYNIC-annexin V. The kidneys had the highest concentration of radioactivity at all time points. Studies in the mouse thymus demonstrated a 40-fold increase in 99mTc-HYNIC-annexin V concentration in apoptotic thymocytes compared with the viable cell population. A correlation of r=0.78 was found between radioactivity and flow cytometric and histologic evidence of apoptosis. Imaging studies in the lpr/lpr and wild-type mice showed a substantial increase of activity in the liver of wild-type mice treated with anti-Fas, while there was no significant change, irrespective of anti-Fas administration, in lpr/lpr mice. Excellent images of hepatic apoptosis were obtained in wild-type mice 30 min after injection of 99mTc-HYNIC-annexin V. The imaging results were consistent with histologic analysis in these animals. In conlusion, these studies confirm the value of 99mTc-HYNIC-annexin V uptake as a marker for the detection and quantification of apoptotic cells in vivo.
引用
收藏
页码:1251 / 1258
页数:7
相关论文
共 47 条
  • [11] Technetium-99m-labeled annexin V imaging for detecting prosthetic joint infection in a rabbit model
    Tang, Cheng
    Wang, Feng
    Hou, Yanjie
    Lu, Shanshan
    Tian, Wei
    Xu, Yan
    Jin, Chengzhe
    Wang, Liming
    [J]. JOURNAL OF BIOMEDICAL RESEARCH, 2015, 29 (03): : 224 - 231
  • [12] Technetium-99m-labeled annexin V imaging for detecting prosthetic joint infection in a rabbit model
    Cheng Tang
    Feng Wang
    Yanjie Hou
    Shanshan Lu
    Wei Tian
    Yan Xu
    Chengzhe Jin
    Liming Wang
    [J]. The Journal of Biomedical Research, 2015, 29 (03) : 224 - 231
  • [13] Analysis of Mechanisms of Interaction between Ciprofloxacin-Based Radiopharmaceutical Labeled with Technetium-99m and Cultured Staphylococcus aureus
    S. I. Sazonova
    M. R. Karpova
    Yu. N. Il’yushenkova
    N. V. Varlamova
    Yu. B. Lishmanov
    [J]. Bulletin of Experimental Biology and Medicine, 2014, 157 : 732 - 734
  • [14] Analysis of Mechanisms of Interaction between Ciprofloxacin-Based Radiopharmaceutical Labeled with Technetium-99m and Cultured Staphylococcus aureus
    Sazonova, S. I.
    Karpova, M. R.
    Il'yushenkova, Yu. N.
    Varlamova, N. V.
    Lishmanov, Yu. B.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 157 (06) : 732 - 734
  • [15] Synthesis and antimicrobial evaluation of two peptide LyeTx I derivatives modified with the chelating agent HYNIC for radiolabeling with technetium-99m
    Fuscaldi, Leonardo Lima
    dos Santos, Daniel Moreira
    Silva Pinheiro, Natlia Gabriela
    Araujo, Raquel Silva
    Branco de Barros, Andre Luis
    Resende, Jarbas Magalhaes
    Antunes Fernandes, Simone Odilia
    De Lima, Maria Elena
    Cardoso, Valbert Nascimento
    [J]. JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES, 2016, 22
  • [16] 99mTc-labeled annexin V fragments:: a potential SPECT radiopharmaceutical for imaging cell death
    Mukherjee, Archana
    Kothari, Kanchan
    Toth, Geza
    Szemenyei, Erzsebet
    Sarma, Hal Dhar
    Kornyei, Jozsef
    Venkatesh, Meera
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2006, 33 (05) : 635 - 643
  • [17] How Does the Concentration of Technetium-99m Radiolabeled Gold Nanoparticles Affect Their In Vivo Biodistribution?
    Apostolopoulou, Adamantia
    Salvanou, Evangelia-Alexandra
    Chiotellis, Aristeidis
    Pirmettis, Nektarios N.
    Pirmettis, Ioannis C.
    Xanthopoulos, Stavros
    Kozminski, Przemyslaw
    Bouziotis, Penelope
    [J]. APPLIED SCIENCES-BASEL, 2024, 14 (10):
  • [18] Evaluation of Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivatives as Potential EGFR Agents
    Makrypidi, Konstantina
    Kiritsis, Christos
    Roupa, Ioanna
    Triantopoulou, Sotiria
    Shegani, Antonio
    Paravatou-Petsotas, Maria
    Chiotellis, Aristeidis
    Pelecanou, Maria
    Papadopoulos, Minas
    Pirmettis, Ioannis
    [J]. MOLECULES, 2023, 28 (04):
  • [19] Uncaria Tomentosa Extract: Evaluation of Effects on the in Vitro and in Vivo Labeling of Blood Constituents with Technetium-99m
    Farias Moreno, Silvana Ramos
    de Carvalho, Jorge Jose
    Nascimento, Ana Lucia
    Olej, Beni
    Rocha, Emely Kazan
    Arnobio, Adriano
    Bernardo-Filho, Mario
    de Araujo Caldas, Luiz Querino
    Honeycut, Hayden
    [J]. BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY, 2008, 51 : 151 - 155
  • [20] Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m
    Klingler, Maximilian
    Rangger, Christine
    Summer, Dominik
    Kaeopookum, Piriya
    Decristoforo, Clemens
    von Guggenberg, Elisabeth
    [J]. PHARMACEUTICALS, 2019, 12 (01)